Page last updated: 2024-09-03

emoxypine succinate and Alloxan Diabetes

emoxypine succinate has been researched along with Alloxan Diabetes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA1
Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA1
Bukina, SJ; Inchina, VI1
Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA2
Slietsans, AA; Snigur, GL; Tiurenkov, IN; Voronkov, AV1

Other Studies

6 other study(ies) available for emoxypine succinate and Alloxan Diabetes

ArticleYear
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
    Bulletin of experimental biology and medicine, 2013, Volume: 155, Issue:1

    Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female; Hippocampus; Hyperglycemia; Male; Meglumine; Neurons; Neuroprotective Agents; Oligodendroglia; Paraventricular Hypothalamic Nucleus; Picolines; Rats; Succinates; Thioctic Acid

2013
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2015, Volume: 101, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid

2015
Neuroprotective activity of mexidole and 3-hydroxypyridine acetylcysteinate against the background of cerebral ischemia in the complex of experimental diabetes mellitus and exogenous hypercholesterolemia.
    Bulletin of experimental biology and medicine, 2008, Volume: 145, Issue:6

    Topics: Acetylcysteine; Animals; Brain Ischemia; Diabetes Mellitus, Experimental; Female; Hypercholesterolemia; Male; Neuroprotective Agents; Picolines; Rats; Treatment Outcome

2008
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:5

    Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid

2011
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:12

    Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hyperlipidemias; Hypoxia; Male; Meglumine; Mice; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Thioctic Acid

2011
[Effects of mexidol and sulodexide on the level of specific markers of endothelial dysfunction in animals with experimental diabetes mellitus].
    Eksperimental'naia i klinicheskaia farmakologiia, 2012, Volume: 75, Issue:5

    Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Endothelin-1; Endothelium; Glycosaminoglycans; Immunohistochemistry; Male; Nitric Oxide Synthase Type III; Picolines; Rats; Vascular Diseases

2012